Premium
Are all P2Y12 equally effective in vein graft angioplasty? A report from the UK database
Author(s) -
Berladi Jorge,
Lamelas Pablo M.
Publication year - 2018
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.27909
Subject(s) - prasugrel , medicine , ticagrelor , clopidogrel , p2y12 , angioplasty , cardiology , regimen , aspirin
Key Points Information of P2Y12 inhibitors in acute coronary syndromes with vein graft angioplasty is limited. This new analysis from the UK database was not able to find significant differences between Clopidogrel, Prasugrel and Ticagrelor. Large trials would be needed to reliably confirm the best antiplatelet regimen in this setting.